Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
about
Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans.Detection of QTL controlling feed efficiency and excretion in chickens fed a wheat-based diet.Diagnosis and treatment of noncardiac chest pain.A role for endogenous peptide YY in tachykinin NK(2) receptor-triggered 5-HT release from guinea pig isolated colonic mucosaEmerging drugs for irritable bowel syndrome.Drugs affecting visceral sensitivity: ready for the prime time?Drug development for the irritable bowel syndrome: current challenges and future perspectivesReview article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.Emerging drugs for postoperative ileus.Novel therapeutic approaches in IBS.Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colon.Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.Investigational agents for the irritable bowel syndrome.Tachykinin NK2 receptor antagonists. A patent review (2006 - 2010).Pharmacodynamic evaluation of Lys5, MeLeu9, Nle10-NKA(4-10) prokinetic effects on bladder and colon activity in acute spinal cord transected and spinally intact rats.Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon.
P2860
Q34668326-53981407-AF4D-44CF-ADFE-36AEDFA7CF8AQ36092760-AECCF2FB-D147-4CBD-AE3F-7021FDCEF689Q36285951-D80D4697-5FC9-4419-9E6A-4E82C6592B8DQ36419333-9E9DB6F5-0BC4-407F-84C6-088B76C2ED0DQ36458417-F7AD84EA-9751-46BE-8DCB-691D50CBB73DQ36478102-140075D5-7292-4DE2-A687-43F78FD06A3DQ36579818-2C084BC3-B2BA-4713-AEA1-FB7A6ED4E3A2Q36583822-124C6299-B99B-4E89-AEC6-8EFB87DF973CQ36989931-F4CB93D5-9455-44F3-904B-5A13C8A2F28BQ37002201-4BE8A797-772F-4F86-82BE-822337E45496Q37084887-FF4457FB-DB91-47B7-8F4A-EB68AA3460A6Q37426287-42CF4D93-7C15-42CE-8C5F-181FEF2AF818Q37788218-0D55A493-EAC8-4515-9AB0-F3A886103F97Q37965737-516B6BCB-9BDA-4699-9AFA-56B4C3DA7574Q38790398-5443A104-36F9-4B17-8487-39E9EF13877DQ39267149-A5259B1F-9FD6-468C-AE56-10CF4824693CQ45982096-BB76B18A-1471-431C-A6C7-88DA155CB235
P2860
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@ast
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@en
type
label
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@ast
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@en
prefLabel
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@ast
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@en
P2093
P2860
P356
P1476
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
@en
P2093
Alessandro Lecci
Angela Capriati
Carlo Alberto Maggi
P2860
P304
P356
10.1038/SJ.BJP.0705751
P407
P577
2004-03-22T00:00:00Z